1 / 19

Intraductal Papillary Mucinous Neoplasms

Intraductal Papillary Mucinous Neoplasms. Intraductal Papillary Mucinous Neoplasm. Grogan JR et al. AJR 176:921-9.2001. IPMN. Spectrum: IPMN adenoma, IPMN borderline lesion, Intraductal papillary mucinous carcinoma. Adenoma. Carcinoma in situ. Invasive carcinoma. IPMN. Main duct type.

vangie
Télécharger la présentation

Intraductal Papillary Mucinous Neoplasms

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Intraductal Papillary Mucinous Neoplasms

  2. Intraductal Papillary Mucinous Neoplasm Grogan JR et al. AJR 176:921-9.2001.

  3. IPMN Spectrum: IPMN adenoma, IPMN borderline lesion, Intraductal papillary mucinous carcinoma Adenoma Carcinoma in situ Invasive carcinoma

  4. IPMN Main duct type Side branch type Grogan JR et al. AJR 176:921-9,2001.

  5. Main duct type IPMN borderline Path: IPMN borderline with no invasive carcinoma

  6. Branch type IPMN adenoma Path : 1 cm branch duct type IPMN adenoma. No invasive carcinoma

  7. Branch type IPMN adenoma Path: 1.2 cm IPMN adenoma. No invasive carcinoma

  8. Combined type IPMN Path: IPMN borderline lesions. No invasive carcinoma

  9. IPMN • Study: 43 pts with IPMN and surgical follow-up. • 13 pts with side branch duct type: • 2 with carcinoma in situ • 0 with invasive carcinoma • 30 pts with main branch duct type: • 6 with carcinoma in situ • 11 with invasive carcinoma Terris, B et al. Am J Surg Pathol 24:1372-1377,2000.

  10. Imaging features predictive of invasive carcinoma • Main pancreatic duct involvement and/or dilatation • Diffuse or multifocal involvement • Presence of large mural nodule or solid mass • Large size of mass • Obstruction of the CBD

  11. Main pancreatic duct involvement Path: ductal adenocarcinoma associated with IPMN with carcinoma in situ. Invasion of duodenal wall and distal CBD. 4 of 10 regional nodes with mets

  12. Diffuse or multifocal involvement Pancreatic duct dilatation affecting > 50% of the extent Lesions involving more than one segment (uncinate process, head, body, tail) Path: IPMN with extensive carcinoma in situ and moderately differentiated ductal adenocarcinoma.

  13. Presence of large (3 mm) mural nodule or solid mass Path: invasive poorly differentiated adenocarcinoma with anaplastic features arising in association with IPMN. Splenic vein invasion. Mets in 1 of 14 lymph nodes

  14. Presence of large (3 mm) mural nodule or solid mass Path: infiltrating moderately differentiated adenocarcinoma of the pancreas Associated with IPMN. Mets in 2 of 10 lymph nodes

  15. Large size of mass • “Large”: various definitions in different studies • > 2 cm: 82% sensitivity and 90% specificity for malignancy • > 3 cm: all cases with malignancy (carcinoma in situ and invasive) • > 5 cm: 54% sensitivity and 94% specificity for invasive carcinoma Path: colloid carcinoma arising in IPMN. Mucinous and necrotic debris with calcifications in mass. Peripancreatic extension and positive nodes.

  16. Obstruction of the CBD • Obstruction caused by direct cancer invasion of the CBD and/or • flow and retention of mucin in the CBD. • > 15 mm or presence of biliary stent: 60% sens and 95% spec • for invasive carcinoma. Path: infiltrating moderately differentiated ductal adenocarcinoma arising in IPMN

  17. IPMN: summary • One of several types of pancreatic cystic lesions • Spectrum: adenoma, borderline, invasive carcinoma • 3 types: side branch, mixed, main duct • Multispecialty approach and follow up often needed • Surgery can be curative

  18. IPMN summary • Predictive features of invasive carcinoma • Main duct involvement and/or dilatation • Diffuse or multifocal involvement • Mural nodule or associated solid mass • Large size of the mass • Obstruction of the CDB

More Related